SP

Salim Pashu Pathan

Active Director Director DIN 11163728
DIN 11163728 First appointment Jun 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Salim Pashu Pathan

Data last updated:

Salim Pashu Pathan is a Director at Arigen Biotech Private Limited (since 2025).

DIN 11163728
Primary Designation Director
First Appointment 27 Jun 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Arigen Biotech Private Limited U72100PN2025PTC243422
Director27 Jun 20252025Active

Directorship timeline

Open interactive timeline →
Arigen Biotech Private Limited
Premium access

Shareholding and investment profile for Salim Pashu Pathan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Salim Pashu Pathan

Salim Pashu Pathan currently holds 1 directorship: Arigen Biotech Private Limited (Director, since 27 Jun 2025).

Salim Pashu Pathan was first appointed on 27 Jun 2025 as Director at Arigen Biotech Private Limited.

The current boards of Salim Pashu Pathan's companies include Abdul Samad Abdul Wahed (Arigen Biotech Private Limited), Imran Rauf Shaikh (Arigen Biotech Private Limited), Kafil Ahemad Husain Khan Pathan (Arigen Biotech Private Limited), Mohammad Faiyaz Anwar (Arigen Biotech Private Limited), Mohammad Razique Mohammad Shamim Shaikh (Arigen Biotech Private Limited), Singal Abutalha Khan Gani Khan (Arigen Biotech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available